Genesis Clinical Research Tampa, FL Medical Director. Fresenius Medical Care Tampa, FL Medical Director. 10/31/1997 to Present
|
|
|
- Todd Gibson
- 6 years ago
- Views:
Transcription
1 Jesus Ovidio Navarro, MD Genesis Clinical Research 4710 N Habana Avenue, Suite 300 Tampa, FL Phone: Fax: genclin@aol.com Licenses and Certifications: Florida ME DEA BN Board Certified Internal Medicine, 1992 Board Certified Nephrology, Memberships: American Society of Nephrology Hillsborough County Medical Association Accomplishments: Low Health-Related Quality of Life Scores in Patients with Anemia and Chronic Kidney Disease J.K. Heifer, W.B. Shapiro, J.O Navarro, J.M. Woolley, J.M. Ford and J. Connolly-Giwa Renal Associates, Little Rock, AR, Brookdale University Hospital and Medical Center, Brooklyn, NY, Genesis Clinical Research, Tampa, FL, Amgen, Inc., Thousand Oaks, CA Chief Administrative Nephrology Fello, , University of Miami, Jackson Memorial Hospital Outstanding third year Internal Medicine Resident, , New York Medical College Metropolitan Hospital Outstanding second year Internal Medicine Resident, , New York Medical Metropolitan Hospital Employment: Genesis Clinical Research Tampa, FL Medical Director and President 10/31/1997 to Present Fresenius Medical Care Tampa, FL Medical Director Kindred Hospital Tampa, FL Chief of Staff 01/01/2013 to Present FMC Carrolwood Tampa, FL Medical Director FMC Ybor Tampa, FL Medical Director
2 FMC Tampa Tampa, FL Medical Director FMC Brandon Tampa, FL Medical Director Fresenius Medical Care-St. Josephs Acute Dialysis Unit Tampa, FL Medical Director 10/31/1997 to Present Internal Medicine and Nephrology Tampa, FL Medical Director and President 10/31/1997 to Present Florida West Coast Clinical Research Group Tampa, FL Principal and Sub Investigator 07/01/1992 to 10/31/1997 Education: University of Miami Miami, FL Nephrology Fellowship 07/01/1990 to 06/30/1992 New York Medical College-Metropolitan Hospital New York, NY Internal Medicine Resident 07/01/1988 to 06/30/1990 Hahnemann University Philadelphia, PA Medical Intern 06/22/1987 to 06/30/1988 Medical College of Pennsylvania-Frankford Hospital Philadelphia, PA Internal Medicine Resident 07/01/1986 to 06/22/1987 North Shore Medical Center Miami, FL Medical Intern 10/01/1984 to 06/12/1986 University of Miami-Miami Veterans Administration Miami, FL Externships 03/01/1984 to 09/01/1984 Additional courses in Rehabilitative Medicine, Diagnostic Radiology and Psychiatry Universidad CETEC Santa Domingo, Dominican Republic Doctor of Medicine 01/01/1981 to 12/10/1983
3 Publications: Navarro. J, Serrano, C., Donna, E., and Perez, G.O. Apneic episodes During Bicarbonate Hemodialysis in COPD; Effect of Cuprophane (CU) Versus Polysulfone Membranes. (Abstract presented, ASN meeting 1991). Navarro.J., Oster, J.R., Gkonos, P.J., Ruiz, JP., Rhamy, R.K., & Perez, G.O. Tetany Induced on Separate Occasions by Administration of Potassium and Magnesium in a Patient with Hungry Bone Syndrome. Mineral Electrolyte Metab 1991; 17: Oster, J.R., Ruiz, J.P., Navarro., Perez, G.O., Clerch, A.R., Cortinas, E.L., and Gold, M.I. Influence of Halothane Hyperbromidemia on Serum Electrolyte and The Anion Gap. Clinical and Toxicology. Ruiz, J.P., Oster, J.R., Navarro., Perez, G.O., Bismo, A.A.L. Low Anion Gap Resulting from Unexplained Exposure to Bromide in a Patient with Renal Amyloidosis, Clinical Toxicology 1992, 30 (4): Navarro, J., Perez and Perez, G.O., Apneic Episodes in Non COPD Patients (Abstract presented in Spain, November 1992, Congreso Hispano Americano de Nephrologia.) Research Experience, Principal Investigator: Fibrogen Present ZSPharma Present Hyperkalemia (Phase III) Otsuka Present ADPKD (Phase III) Amgen Present ND-CKD (Phase III) Novo Nordisk DMI (Phase III) Astrazeneca Diabetes II (Phase III) Lilly DKD/HTN (Phase II) Trevi Uremic Pruritus (Phase III) Astrazeneca Hyperphophatemia (Phase II) Amgen Hyperparathyroidism (Phase II) Akebia Anemia (Phase II) ZSPharma Hyperkalemia (Phase III) Otsuka ADPKD (Phase II) Mitsubishi
4 Pruritus (Phase II) Sandoz CKD/ Lilly DKD/HTN (Phase II) Boehringer 2010 to 2012 CKD in Non-Insulin Patients (Phase III) Boehringer 2010 to 2012 Diabetes/CKD GlaxosmithKline 2010 to 2012 Hypertension (Phase II) Fibrogen 2010 to 2012 Anemia/CKD (Phase II) Forest 2010 to 2011 Johnson & Johnson 2010 to 2011 Type II Diabetes (Phase II) Luitpold 2009 to 2011 Anemia/CKD Amgen/Treat 2004 to 2009 Anemia/CKD Amgen 2008 to 2012 Phosphate Binder/HD (Phase II) Genetech 2007 to 2009 Vascular Access Patency Affy 2008 to 2010 Anemia/HD Affy 2008 to 2010 Anemia/CKD Abbott 2008 to 2009 Hyperparathyroidism/CKD (Phase IV) Abbott 2008 to 2009 Hyperparathyroidism/HD (Phase IV) Select/Post Marketing 2007 to 2012 Phosphate Binder/HD Kremzin 2007 to 2012 CKD NovoNordisk 2007 to 2008 Growth Hormone Evolve 2007 to 2012 Hyperparathyroidism/HD (Phase IV) Amgen 2006 to 2010 Anemia/CKD Johnson & Johnson 2006 to 2007
5 Anemia/CKD (Phase IV) Luitpold 2005 to 2006 Amgen 2005 to 2006 Hemodialysis/Peritoneal Dialysis (Phase III) Watson Laboratories 2005 to 2006 Iron Deficiency/Dialysis (Phase IV) Advanced Magnetics 2005 to 2005 Iron Deficiency in CRI (Phase III) Ortho Bio-Tech 2005 to 2006 Anemia (Phase II) Advanced Magnetics 2004 to 2005 Iron Deficiency in ESRD (Phase III) Amgen 2004 to 2005 Amgen 2004 to 2009 Anemia/CKD (Phase IV) Amgen 2004 to 2005 Hyperparathyroidism (Phase III) Amgen 2003 to 2005 Hyperparathyroidism (Phase III) Ortho Bio-Tech 2002 to 2005 Ortho Bio-Tech 2002 to 2003 Pfizer 2002 to 2002 Dyslipidemia (Phase IV) Amgen 2002 to 2003 Hemodialysis/Peritoneal Disease (Phase III) Amgen 2002 to 2003 Hemodialysis/Peritoneal Disease (Phase IV) Amgen 2002 to 2003 Hyperparathyroidism in CRI (Phase III) Amgen 2002 to 2003 Anemia Registry (Phase IV) Amgen 2002 to 2003 Anemia Monthly Dosing (Phase IV) Amgen 2002 to 2004 Anemia in Dialysis Population (Phase III) Abbott 2002 to 2002 Hyperparathyroidism (Phase IV) Depomed 2002 to 2002 Diabetes (Phase III)
6 Glaxosmithkline 2002 to 2003 Glaxosmithkline 2002 to 2003 Diabetes (Phase III) Berlex 2002 to 2003 Hormone Replacement Therapy (Phase III) Bayer 2002 to 2002 Erectile Dysfunction (Phase IV) Ortho Bio-Tech 2001 to 2002 Anemia Registry (Phase IV) Bristol-Myers 2001 to 2002 Luitpold 2001 to 2003 Iron (Phase III) Geltex 2001 to 2003 Phosphate and ESRD (Phase III) Amgen 2001 to 2001 Sleep Disorder (Phase III) Amgen 2001 to 2001 Novartis 2000 to 2001 Solvay 2000 to 2001 Bristol-Myers-Squibb 2000 to 2001 Amgen 2000 to 2001 Anemia and CRI (Phase III) Luitpold 2000 to 2001 IV Iron (Phase III) Amgen 2000 to 2001 Chronic Renal Insufficiency Registry (Phase IV) Amgen 2000 to 2001 Anemia and CRF (Phase III) Bayer 2000 to 2001 Hypercholesterolemia and ESRD (Phase III) Schire Labs 1999 to 2002 Phosporus and ESRD(Phase III) Schein 1999 to 2000 Iron in ESRD (Phase IV) Merck & Co to 2000 Hyperlipidemia in High Risk Groups (Phase IV)
7 BCI 1998 to 1999 Hyperparathyroidism and ESRD Bristol-Myers/Squibb 1997 to 1997 Hypertension Amylin 1997 to 1997 Insulin Dependency Elan/SciRex 1997 to 1997 Hypertension Pfizer 1997 to 1997 Isolated Hypertension Searle 1997 to 1997 Hypertension (Phase II) Searle 1997 to 1997 Elan 1996 to 1997 Merck & Co to 1997 Merck & Co to 1997 Hypertension and LVH (Phase IV) Bristol-Myers-Squibb 1995 to 1997 Diabetic Neuropathy (Phase III) Parke Davis 1995 to 1997 Acute CVA (Phase III) Smith Kline Beecham 1995 to 1997 Hypertension (Phase II) Amgen 1995 to 1996 CHF/Anemia/ESRD (Phase IV Boeringer Ingelheim 1995 to 1997 Ace Induced Cough (Phase III) Scios Nova 1995 to 1997 Oliguric Acute Renal Failure (Phase III) Boeringer Ingelheim 1995 to 1996 Bristol-Myers-Squibb 1995 to 1996 Hypertension (Phase II) Pfizer 1995 to 1996 Bayer 1995 to 1996 Bristol-Myers-Squibb 1994 to 1996 UPSA 1994 to 1996
8 UPSA 1994 to 1996 Sankyo/Parexel 1993 to 1997 Amgen 1993 to 1997 Anemia in ESRD (Phase IV) BioPharm/Rorer 1993 to 1996 Pneumonia (Phase III) MSD 1993 to 1996 Renal and sever Hoffman-La Roche 1993 to 1996 Obesity (Phase III) MSD 1993 to 1995 Renal Miles 1993 to 1996 Diabetes (Phase II) Scios Nova 1993 to 1995 Acute Renal Failure(Phase III) Boehringer Mannheim 1993 to 1995 Rhoune-Poulenc-Rorer 1993 to 1994 Pneumonia (Phase III) Rhoune-Poulenc-Rorer 1993 to 1994 Acute Bronchitis (Phase III) Pfizer 1993 to 1994 African Americans and Bio/Pharm/Rore 1993 to 1994 Acute Bronchitis (Phase III) Marrion Merrill Dow 1993 to 1994 Medex 1993 to 1994 Pneumonia (Phase II) Miles 1993 to 1994 Pact 1993 to 1994 Sleep Disorder (Phase IV) Warner Lambert/Parke Davis 1993 to 1993 Diabetes (Phase II) Warner Lambert/Parke Davis 1993 to 1993 Hypertriglyceridemia (Phase II) Nippon Chemiphar 1992 to 1993
9 Miles 1992 to 1994 MSD 1992 to 1994 Renal and MSD 1992 to 1994 Severe Marion Merrill Dow 1992 to 1993 Knoll Pharmaceuticals 1992 to 1993 Rhone Poulenc-Rorer 1992 to 1993 MSD 1991 to 1994 EM Industries 1991 to 1993
Robert Perlstein, M.D. Medical Officer. Center for Drug Evaluation and Research. U.S. Food & Drug Administration
-------------------- Robert Perlstein, M.D. Medical Officer Center for Drug Evaluation and Research U.S. Food & Drug Administration -------------------- Sentencing of Food and Drug Offenses Before the
Name of Company Involved. Exact or Estimated Value. Accepted / Refused
202 Simon Duckett Cardiology Consultant 25/09/2017 Sponsorship 232 N/A N/A N/A 06/11/2017 Sponsorship 241 N/A N/A N/A 14/11/2017 Sponsorship 245 N/A N/A N/A 17/11/2017 Sponsorship 246 N/A N/A N/A 17/11/2017
UnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2018-9 Program Prior Authorization/Medical Necessity Topical Androgens Medication Axiron*, Androderm, Androgel*, Fortesta*, Natesto*,
Author of: The Six-Pack Diet Plan: The Secrets to Getting Lean Abs and a Rock-Hard Body Permanently
Interview with Rehan Jalali, President, Supplement Research Foundation Author of: The Six-Pack Diet Plan: The Secrets to Getting Lean Abs and a Rock-Hard Body Permanently Background Information: According
Insight into male menopause'
Insight into male menopause' Dr Mark Vanderpump MD FRCP Consultant Endocrinologist Clinics: Tuesday PM Mark Vanderpump Consultant Physician and Endocrinologist Introduction Serum total and free testosterone
Paving the Path to Patients Content Expertise
Learning Lab 19 This presenter has nothing to disclose Paving the Path to Patients Content Expertise Chris Sarfaty MSW Dori Schatell MS Britt-Mari Banck RN Nancy Spaeth RN Richard Gibney MD Sunday, Dec.
Issues. What is a low testosterone? Who needs testosterone therapy? Benefits/adverse effects of testosterone replacement Treatment options
Male Hypogonadism Jauch Symposium Waterloo, IA May 17, 2013 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships with any proprietary entity producing
The Future of Puerto Rico s Economic Development: Towards an Economy Based on Knowledge
The Future of Puerto Rico s Economic Development: Towards an Economy Based on Knowledge Eighth Annual Caribbean Conference on Sustainable Tourism Development April 29, 2006 1 AGENDA Puerto Rico s Position
Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent
Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent Androgens/Anabolic Steroids Prior Authorization with Quantity Limit Through Preferred
International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Review Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com NANDROLONE DECANOATE VERSES ERYTHROPOIETIN FOR TREATMENT
Hospital Admissions in the Northern Territory
Hospital Admissions in the Northern Territory 1976-28 www.healthynt.nt.gov.au Hospital Admissions in the Northern Territory, 1976 to 28 Shu Qin Li Sabine Pircher Steve Guthridge John Condon Jo Wright Acknowledgements
Hyperbaric Oxygen Therapy Unit
Hyperbaric Oxygen Therapy Unit Indraprastha Apollo Hospital. New Delhi A decade of practice of hyperbaric Medicine 1 Introduction Dr PC Reddy is a great visionary and introduced many new treatment modalities
HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other METHYL ANDROID METHITEST METHYL TESTRED 01404 ROUTE MISCELL. CYPIONATE ENANTHATE GUIDELINES FOR USE ANDRODERM ANDROGEL AXIRON FORTESTA NATESTO STRIANT TESTIM VOGELXO
Nephrology Unit, Department of Medicine, Bayero University, Kano, PMB 3452, Nigeria 2
International Nephrology Volume 2012, Article ID 580437, 6 pages doi:10.1155/2012/580437 Research Article Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of
PRODUCT INFORMATION PRIMOTESTON DEPOT. (testosterone enantate)
PRODUCT INFORMATION PRIMOTESTON DEPOT (testosterone enantate) NAME OF THE MEDICINE Testosterone enantate is designated chemically as 17 beta-heptanoyloxy-4-androstene-3- one. The empirical formula of testosterone
Natural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone
Natural Hair Transplant Medical Center, Inc. 1000 Dove Street, Suite #250, Newport Beach, CA 92660 Phone-949-622-6969 Finasteride (PROPECIA ) Acknowledgement Finasteride is an oral medication, manufactured
Testosterone Hormone Replacement Drug Class Prior Authorization Protocol
Testosterone Hormone Replacement Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective date: April 1, 2018 This policy has been developed through
BALTIC STATES PHARMA MARKET OVERVIEW. Secondary sales analysis
BALTIC STATES PHARMA MARKET OVERVIEW Secondary sales analysis Content Introduction General overview Sales dynamics in Baltic states 2009 2014 Generic / Originator drugs market share in Baltic states 2013
IPR Rituxan 8,545,843 2-Nov-17 Pfizer, Inc. Biogen, Inc. Denied Pending N/A
Trial Drug (if applicable) Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD
CURRICULUM VITAE PAUL CIANCI, M.D., F.A.C.P. F.U.H.M. Springfield College, Springfield, Massachusetts (Biology with highest praise)
CURRICULUM VITAE PAUL CIANCI, M.D., F.A.C.P. F.U.H.M Present Position: Medical Director, Department of Hyperbaric Medicine Doctors Medical Center, San Pablo, CA Past Positions: Emeritus Medical Director,
b. Provide consultation service to physicians referring patients. c. Participate in weekly wound care clinic and biweekly diving medicine clinic.
Curriculum: 1. Required clinical activities: a. Participate in HBO 2 clinical operations by monitoring daily treatment sessions and emergency on-call treatments at least 4 days/week, b. Provide consultation
Stanford Coordinated Care
Stanford Coordinated Care Extreme Team Care April 20, 2015 Determinants of Health and Their Contribution to Premature Death 15% 30% 5% 10% Social Environmental Medical Behavioral Genetic 40% Schroeder,
Patient Controlled Analgesia (PCA)
2012 Patient Controlled Analgesia (PCA) Patient Controlled Analgesia (PCA) What is PCA? PCA is Patient- Controlled Analgesia. The PCA machine gives you control over managing your pain. When you need pain
How the SNOMED CT to ICD-10 Map facilitated the map to a national extension of ICD-10
How the SNOMED CT to ICD-10 Map facilitated the map to a national extension of ICD-10 Kin Wah Fung, MD, MS, MA U.S. National Library of Medicine, Bethesda, MD, USA Why do we need a map from SNOMED CT to
PROGRAM 2003 ANNUAL MEETING. American Psychiatric Association. The Promise of Science The Power of Healing AMERICAN PSYCHIATRIC ASSOCIATION
PROGRAM AMERICAN PSYCHIATRIC ASSOCIATION 2003 ANNUAL MEETING American Psychiatric Association 10 I 674 I The Promise of Science The Power of Healing 156th Annual Meeting + May 17-22, 2003 San Francisco,
OTM Patent Coordinator. Biomedical and Health Information Sciences Lauren Segal Anne Burkhart Architecture, School of Mark Krivchenia Anne Burkhart
College of Applied Health Science College of Architecture, Design, and the Arts Biomedical and Health Information Sciences Lauren Segal Anne Burkhart Architecture, School of Mark Krivchenia Anne Burkhart
UPDATED RANKING LIST
Current RK2014 RK2013 AMS14 Roche Fresenius Medical Care 1.292,00 67,00 1.359,00 1.215,50 124,00 1.339,50 Baxter - Gambro Renal (former Gambro) 1.070,50 98,00 1.168,50 Amgen 1.016,00 71,50 1.087,50 Janssen
LOBBYISTS LISTED BY RECEIPTS RANKING
CALENDAR YEAR 1998 S LISTED BY RANKING DATE 2/16/99 NJ CABLE TELECOMMUNICATIONS ASSN 822,464.00 2/10/99 CHEMICAL INDUSTRY COUNCIL OF NJ 152,451.30 2/16/99 NJ CHAPTER NATIONAL SOLID WASTE MANAGEMENT NSWMA
Let s Talk Period: Women and Bleeding Disorders
Let s Talk Period: Women and Bleeding Disorders Paula James MD, FRCPC 18 th Australian & New Zealand Conference on Haemophilia and Rare Bleeding Disorders October 14, 2017 Disclosures for Paula James Potential
SPONSORSHIP 2008 guide
SPONSORSHIP 2008guide Prix Galien USA Committee Michael S. Brown, M.D. Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center at Dallas Prix Galien in the wor l d Prix Galien
The ICL Insider. Lab Testing: Testosterone. In This Issue. The Debate
The ICL Insider February 2017 Volume 2, Issue 2 Lab Testing: Testosterone In This Issue Testosterone shashtilak@iclabs.ca Next Issue: Expected Release April 2017 The Debate Aging is accompanied by various
Welcome to the 20 th anniversary meeting of ESPACOMP in Lisbon
Welcome to the 20 th anniversary meeting of ESPACOMP in Lisbon Local chair Local partner Prof. Filipa A. Costa 20 th anniversary meeting of ESPACOMP Lowlands 996-2005 The 20 th ESPACOMP Annual Meeting
AN-SNAP Class allocation. There are two steps to allocating a SNAP class for each patient
AN-SNAP Class allocation There are two steps to allocating a SNAP class for each patient SNAP class allocation Step 1 1. The impairment code must be allocated. There are two over-riding rules that need
Team Knightro Tryout Checklist
Team Knightro Tryout Checklist What to Bring the First Day of Tryouts 1. Bring a "copy" of either your UCF Student I.D. or "copy" of your acceptance letter. * Please do not bring the originals as a copy
AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE
AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires disclosure, by presenters at CME activities, of any significant financial
SCHOOL SUPPLIES DRIVE
Chamber of Commerce Newsletter A PUBLICATION OF THE LAKE ALFRED CHAMBER OF COMMERCE Office Manager Marilyn September 2017 Edition SCHOOL SUPPLIES DRIVE On August 9, the Lake Alfred Chamber of Commerce
The Australian and New Zealand College of Veterinary Scientists. Membership Examination. Medicine of Horses Paper 1
The Australian and New Zealand College of Veterinary Scientists Membership Examination June 2012 Medicine of Horses Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours after perusal
5 THINGS TO KNOW IN Vail R. Brown, STR
5 THINGS TO KNOW IN 2014 Vail R. Brown, STR VAIL R. BROWN Vice President of Global Business Development and Marketing for STR. Mrs. Brown is responsible for the overall coordination, functional management
Panzyga Administration Guide
Immune Human Normal Globulin Immunoglobulin Intravenous (Human) (IVIg) Octapharma s new Intravenous Immunoglobulin (IVIG) Panzyga Administration Guide An educational service tool provided by Octapharma
Contacts. Quick Start Guide
Contacts Clinical Support Specialist: Phone: Cell Phone: Email: Fresenius Renal Technologies A division of Fresenius Medical Care North America 920 Winter Street Waltham, MA 02451 Technical Service Customer
WORKSHOP ON INCREASING RATES ON ORGAN DONATION -INSTITUTE OF MEDICINE-
WORKSHOP ON INCREASING RATES ON ORGAN DONATION -INSTITUTE OF MEDICINE- RAFAEL MATESANZ DIRECTOR ONT - SPAIN (SPANISH NATIONAL TRANSPLANT ORGANIZATION) UNIVERSAL PROBLEM 30 SPAIN 30 USA 20 10 20 ITALY
Testosterone Hormone Replacement Drug Class Prior Authorization Protocol
Line of business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 Testosterone Hormone Replacement Drug Class Prior Authorization Protocol This policy has been developed through
RESUME. Xia Zhou, M.D. Education. Employment. Honor and Awards
RESUME Xia Zhou, M.D. Department of Biological Sciences Room 282, Life Sciences Building University of Idaho P.O. Box 443051 Moscow, ID 83844-3051 Tel: (208) 885-2583/885-6905 Email: zhouxia@uidaho.edu
Antiduretic Hormone, Growth. Hormone & Anabolic Steroids
Goudarz Sadeghi, DVM, PhD, DSc Associate Professor of Pharmacology University of Tehran Faculty of Veterinary Medicine Veterinary Pharmacology Endocrine System Antiduretic Hormone, Growth Hormone & Anabolic
23rd Annual FLCMAA Sunshine Charity Golf Tournament 2018 Sponsorship Opportunities
23rd Annual FLCMAA Sunshine Charity Golf Tournament 2018 Sponsorship Opportunities Beneficiary Information Logan, only 23 months old, has been a patient at Orlando Health Arnold Palmer Hospital for Children
London Respiratory Team
London Respiratory Team By email 28 March 2012 Ambulatory Oxygen for London This guide has been produced to help healthcare maximise the benefit of the new oxygen contract for patients and to reduce waste.
Information for Vermont Prescribers of Prescription Drugs (Long Form)
Information for Vermont Prescribers of Prescription Drugs (Long Form) LONSURF (tipiracil and trifluridine) tablets This list does not imply that the products on this chart are interchangeable or have the
Drug Class Monograph
Drug Class Monograph Class: Testosterone Hormone Replacement Drug: Androderm (testosterone transdermal system), Androgel (testosterone topical gel), Axiron (testosterone topical solution), Aveed (testosterone
QUESTIONNAIRE FOR MEMBERS OF THE PUBLIC
MAHSC Oxygen Project. Questionnaires for members of the public V1 10-12-2011 QUESTIONNAIRE FOR MEMBERS OF THE PUBLIC We would like to know what you think about oxygen therapy as a member of the public.
Global Use of Plasma-Derived Medicinal Products
Global Use of Plasma-Derived Medicinal Products Patrick Robert The Marketing Research Bureau, Inc. IPFA Workshop on Improving Access to Plasma and Plasma Products in the Southern African Region December
Secrets of Abang Sado : Effects of testosterone therapy. Azraai Nasruddin
+ Secrets of Abang Sado : Effects of testosterone therapy Azraai Nasruddin + Testosterone Testosterone : Steroid hormone - Made primarily by the testicles in males - Small amounts produced by the adrenal
CURRICULUM VITAE Michael F. Burns, M.D.
CURRICULUM VITAE Michael F. Burns, M.D. OFFICES: Division of Signature Medical Group, Inc 845 N New Ballas Court, Suite 200 St. Louis, MO 63141 Telephone: (314) 983-4700 Fax: (314) 995-7103 Division of
MI Androgen Deficiency Hypogonadism
MI Androgen Deficiency Hypogonadism WADA TUE Expert Group John A Lombardo, MD October 2014, Columbus, Ohio USA Hypothalamic-Pituitary-Gonadal Axis / 2 Hypogonadism/Androgen Deficiency Clinical syndrome:
Implementing ICD-10-CM Preparing for the Conversion
ICD-9-CM ICD-10-CM Implementing ICD-10-CM Preparing for the Conversion AHIMA Long Term and Post Acute Care Practice Council 1 Users are encouraged to adapt these slides as long as they in no way suggest
PRODUCT INFORMATION. Testosterone Phenylpropionate: Testosterone Phenylpropionate is 3-oxoandrost-4-en-17β-yl
PRODUCT INFORMATION SUSTANON '250' NAME OF THE MEDICINE Sustanon '250' ('250' mg/ml for injection): testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, testosterone decanoate.
LIGHTHOUSE. Stopper Pop-Up and the Effects on. Container Closure of Sterile Vials. Application Note 101 LIGHTHOUSE
Stopper Pop-Up and the Effects on Container Closure of Sterile Vials Stopper Pop-Up and the Effects on Container Closure of Sterile Vials Introduction Container closure integrity plays an important role
Corporate Sponsorship Invitation
26 th Annual Hit Em for Hemophilia Golf Tournament Tuesday, October 28, 2008 Château Élan Winery and Resort Braselton, Georgia Corporate Sponsorship Invitation A Benefit for Hemophilia of Georgia 26 th
Health Beyond Healthcare The Chronic Disease Impacts of Neighborhood Design. Erik J. Aulestia, AICP Principal, Torti Gallas + Partners
Health Beyond Healthcare The Chronic Disease Impacts of Neighborhood Design Erik J. Aulestia, AICP Principal, Torti Gallas + Partners Prior to 20th Century How should a city look and function? Architects
The Demographics of US Drowning & Data on Guarded Pool Deaths Julie Gilchrist, M.D.
The Demographics of US Drowning & Data on Guarded Pool Deaths Julie Gilchrist, M.D. Dr. Julie Gilchrist is a Pediatrician and Medical Epidemiologist with the National Center for Injury Prevention and Control
Lessons Learned. Angeles National Forest June 8, Heat-related illness; Interagency Hotshot Crew (IHC) crewmember
Angeles National Forest June 8, 2014 Heat-related illness; Interagency Hotshot Crew (IHC) crewmember Hey Cap. I m callin it! [The crewmember] needs to go to the hospital. EMT rendering aid to crewmember.
Jean Byers Award for Excellence in Cancer Registration
per 1100 Shands University of Florida 2002 2004 2005 2007 2009 2011 2012 2014 2015 2016 10 1105 Shands Alachua General Hospital 2002 2003 2004 2005 2008 5 1170 North Florida Regional Medical Center 1997
MATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Package Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)
Package Leaflet: Information for the patient Sustanon 250, 250 mg/ml, solution for injection (testosterone esters) Read all of this leaflet carefully before you start using this medicine because it contains
JERRY D. PARRISH, PH.D. Chief Economist Florida Chamber
JERRY D. PARRISH, PH.D. Chief Economist Florida Chamber Foundation jparrish@flfoundation.org @DrJerryParrish 2007 2007 2014 US versus Florida Coincident Indicators 190 180 170 160 150 140 130 120 110 100
Diag Trend Report. HHA Paid Claims Data: Jul 13 Dec 13 Three Digit Primary Diag Codes % Diag Beneficiaries in each state
Diag Trend Report Based On: HHA Paid Claims Data: Jul 13 Dec 13 Three Digit Primary Diag Codes in each state Graphs show trend in top five diag codes (Identified in terms of % diag beneficiaries during
Testosterone Topical/Buccal/Nasal
BENEFIT APPLICATION Testosterone Topical/Buccal/Nasal DRUG POLICY Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations
Connecting the Pieces CROWNWeb and ICD-10: What You Need to Know With CROWNWeb Outreach, Communication, and Training (OCT)
CROWNWeb and ICD-10: What You Need to Know With CROWNWeb Outreach, Communication, and Training (OCT) September 17, 2015 2pm ET 3pm ET Streaming Audio Audio for this event is available via INTERNET STREAMING
Revisiting respiratory failure
Clinical corner Revisiting respiratory failure by Richard D. Pinson, MD, FACP, CCS The diagnosis and documentation of respiratory failure continues to be challenging for coders, documentation specialists,
Perfusion Safety Review in Japan
Perfusion Safety Review in Japan Atsushi SEKIGUCHI Department of Medical Engineering, Saitama International Medical Center, Saitama, JAPAN and Secretary General, JaSECT; The Japanese Society of Extra-corporeal
Material Safety Data Sheet
Page 1 of 5 Issue Date: June 2010 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION River Sands Pty Ltd ACN 009 919 215 ABN 41 009 919 215 683 Beenleigh Redland Bay Rd CARBROOK QLD 4129 Tel: +61 7 3287 6444
Subj: HYPERBARIC OXYGEN TREATMENT IN NAVY RECOMPRESSION CHAMBERS
DEPARTMENT OF THE NAVY BUREAU OF MEDICINE AND SURGERY 7700 ARLINGTON BOULEVARD FALLS CHURCH, VA 22042 IN REPLY REFER TO BUMEDINST 6320.38C BUMED-M95 BUMED INSTRUCTION 6320.38C From: Chief, Bureau of Medicine
CGuard MicroNet-Covered Embolic Prevention Stent System A Game Changer in Carotid Revascularization
CARENET J Am Coll Cardiol 2015;66:B33 CGuard MicroNet-Covered Embolic Prevention Stent System A Game Changer in Carotid Revascularization Piotr Musialek, MD DPhil FESC Jagiellonian University Dept. of
TESTOVIRON 300 TESTOCYP 200 INJECTABLE PRODUCTS
Platinum Biotech has a commitment to all people, a commitment of improving the quality of life for each and every person worldwide, through which we constantly strive to innovate, improve and increase
Ensuring Patient Safety and Quality- Water Standards. Eileen Lischer MA, BSN, RN,CNN University of California San Diego
Ensuring Patient Safety and Quality- Water Standards Eileen Lischer MA, BSN, RN,CNN University of California San Diego AAMI Historically Acute programs have been held to a more relaxed safety design standard
Deborah Dewaay MD Division of General Internal Medicine and Geriatrics Hospital Medicine Acknowledgment: Antine Stenbit MD
Deborah Dewaay MD Division of General Internal Medicine and Geriatrics Hospital Medicine 2013 Acknowledgment: Antine Stenbit MD Objectives Knowledge: Understand the difference between hypoxia and hypoxemia
Oxygen prescription. Dr Julian Forton. Consultant in paediatric respiratory medicine Noah s Ark Children s Hospital for Wales
Oxygen prescription Dr Julian Forton. Consultant in paediatric respiratory medicine Noah s Ark Children s Hospital for Wales Oxygen prescription chart EXCEPTION: Oxygen may be given without a prescription
S.I.T.E.M.S.H Congress
S.I.T.E.M.S.H Congress Tehran University of Medical Sciences (TUMS) December 2015, Tehran Farzin Halabchi M.D. Associate Professor, Sports & Exercise Medicine, TUMS Head, Iranian Association of Sports
PRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)
PRODUCT INFORMATION TESTOVIRON DEPOT (testosterone enanthate) NAME OF THE MEDICINE Testosterone enanthate is designated chemically as 17 beta-heptanoyloxy-4-androstene-3- one. The empirical formula of
INTRODUCTION TO HYPERBARIC MEDICINE
1 INTRODUCTION TO HYPERBARIC MEDICINE Physician Hyperbaric Training and Certification Approved for: 42 AMA, PRA CATEGORY 1 CME Credit Hours for Physicians Nurse / Technician Hyperbaric Training (CEUs issued
TESTOFEN HUMAN CLINICAL TRIAL GENCOR PACIFIC, INC. Copyright 2006 by Gencor Pacific, Inc.
GENCOR PACIFIC, INC. 920 E. Orangethorpe Avenue, Suite B, Anaheim, CA 92801 Ph: 714.870.8723 714.870.8724 efax: 732.875.0306 drjit@gencorpacific.com gita@gencorpacific.com www.gencorpacific.com TESTOFEN
M0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:
M0BCore Safety Profile Active substance: Finasteride Pharmaceutical form(s)/strength: 5 mg P-RMS: SE/H/PSUR/0002/006 Date of FAR: 16.05.2014 4.3 Contraindications Finasteride is not indicated for use in
Leading Causes of Death in Hawaii
Leading Causes of Death in Hawaii Death Counts, Age-Adjusted Mortality Rates, and Years of Potential Life Lost for the State of Hawaii (Residents Only), by Cause of Death, by This report displays the average
Leading Causes of Death in Hawaii
Leading Causes of Death in Hawaii Death Counts, Age-Adjusted Mortality Rates, and Years of Potential Life Lost for the State of Hawaii (Residents Only), by Cause of Death, by This report displays the average
Hyperbaric Oxygen Technician Training Program By Charles J Peters
Hyperbaric Oxygen Technician Training Program By Charles J Peters If you are searched for the ebook by Charles J Peters Hyperbaric oxygen technician training program in pdf form, then you've come to the
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 June 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 20 June 2012 CINRYZE 500 units, 2100 IU, powder and solvent for solution for injection B/2 bottles (CIP code: 218
Committee on Issues in Organ Donor Intervention Research. Presented by: Richard D. Hasz Vice President, Clinical Services
Committee on Issues in Organ Donor Intervention Research Presented by: Richard D. Hasz Vice President, Clinical Services Living Organ Donors 5,527 U.S. National Trends in Organ Donation Living vs. Deceased
Donald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May Terry s Testosterone
Focus on CME at University of Alberta ADAM: Dealing with the Decline Donald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May 2005 We now know there is a decline in total
BARCELONA HALL 8 - GRAN VIA BARCELONA
th EUROPEAN MEETING ON HYPERTENSION AND CARDIOVASCULAR PROTECTION JUNE 8-11, 2018, FIRA BARCELONA HALL 8 - GRAN VIA BARCELONA PRELIMINARY INFORMATION WELCOME MESSAGE Dear Colleagues, It is my great pleasure
Perfluorochemical (PFC) Investigation Public Meeting: PFC Blood Testing & Long Term Water Solutions
Perfluorochemical (PFC) Investigation Public Meeting: PFC Blood Testing & Long Term Water Solutions Hosted by NH Department of Health and Human Services NH Department of Environmental Services Litchfield,
MATERIAL SAFETY DATA SHEET GLUTOSE SECTION 1 - PRODUCT IDENTIFICATION AND HAZARDOUS COMPONENTS
MATERIAL SAFETY DATA SHEET GLUTOSE PADDOCK LABORATORIES, INC. 3940 QUEBEC AVENUE NORTH MINNEAPOLIS, MINNESOTA 55427 PHONE: (763)-546-4676 EMERGENCY ASSISTANCE: CHEMTREC 800-424-9300 202-483-7616 PADDOCK
한국학술정보. Educational Effect on Prehospital Personnel for Prehospital Stroke Management
Educational Effect on Prehospital Personnel for Prehospital Stroke Management Jin Hyun Yoo, M.D., Eun Kyung Eo, M.D. 1, Yong Jae Kim, M.D. 2, Hwa Sik Song, M.D. P u r p o s e: If optimal neurologic recovery
YOUR PERSONAL OXIMETER:
YOUR PERSONAL OXIMETER: A Guide for Patients by Thomas L. Petty, M.D. TABLE OF CONTENTS Introduction...1 The Body s Need for Oxygen...2 At rest...2 Exercise and sleep...2 During travel...3 So Your Doctor
Energy Metabolism. Symptoms of Tying-up
TYING-UP IN HORSES Research Leads to Dietary and Exercise Management Strategies by Stephanie J. Valberg, D.V.M., Ph.D., College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota Tying-up,
The Testosterone Quandary. Beth Crowder, PhD, APRN
The Testosterone Quandary Beth Crowder, PhD, APRN Objectives Define testosterone, the hypothalamic-pituitary-gonadotrophic axis, and normal blood levels List functions of testosterone and symptoms of low
New Directions in Aplastic Anemia: What is on the Horizon
Case Presentation #1 New Directions in Aplastic Anemia: What is on the Horizon Gabrielle Meyers, MD 62 y/o male, with hypertension, who presented to his PCP for evaluation of fatigue, shortness of breath
Icd-10 low levels of testosterone
Icd-10 low levels of testosterone The Borg System is 100 % Icd-10 low levels of testosterone 1-10-2017 if your hormone levels are too high or too low, you may have a hormone disorder. Hormone diseases
Leader: Anne Coble Voss, PhD, RD, LD, Abbott Nutrition, Columbus, OH
Discussion Leader: Anne Coble Voss, PhD, RD, LD, Abbott Nutrition, Columbus, OH Dr Tisdale: Dr Bosaeus, you suggested that the drive to synthesize acute-phase proteins by the liver was actually driving
MEDICAL DEPARTMENT PASSENGER INFORMATION PHYSICIAN INFORMATION
MON-FRI 06:00-20:00 EST MEDICAL DEPARTMENT SAT-SUN 06:00-18 :00 EST Email : acmedical@aircanada.ca Fax 1-888-334-7717 (Toll-free from North America) Telephone 1-800-667-4732 (Toll-free from North America)
Hotel InduSTRy Overview What Lies Ahead
Hotel InduSTRy Overview What Lies Ahead Vail R. Brown Vice President, Global Business Development & Marketing www.hotelnewsnow.com Click on Hotel Data Presentations U.S. In Review Demand Growth Strong.
Beyond Bullet Points: Statistics, Trends and Analysis
Beyond Bullet Points: Statistics, Trends and Analysis Vail R. Brown VP, Global Business Development & Marketing Vail@str.com @vail_str 5 THINGS TO KNOW www.hotelnewsnow.com Click on Data Presentations